OPTN Liver and Intestinal Organ Transplantation Committee Update Spring 2012 Kim Olthoff, MD, Chair David Mulligan, MD, Vice-chair.

Slides:



Advertisements
Similar presentations
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Advertisements

Concentric Circle Liver Distribution Models
Liver and Intestinal Organ Transplantation Committee Update on Liver Allocation and Distribution ACOT August 28, 2012 Kim M. Olthoff, MD, Chair David C.
OPTN Session 3 OPTN Policy Development and Feedback from RFI / Highlights of concepts being explored April 12, 2010.
Liver and Intestinal Organ Transplantation Committee Spring 2014 Update.
UNOS Update.  Updating 2012 Strategic plan  Planning for OPTN and UNOS Strategic Planning RegionsBoard Executive Committee /CAC Community.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Proposal to Change the OPTN/UNOS Bylaws to Better Define Notification Requirements for Periods of Functional Inactivity Membership and Professional Standards.
Proposed Revisions to and Reorganization of Policy 6.0 (Transplantation of Non-Resident Aliens) Sponsors: Ad Hoc International Relations Committee and.
Proposal to Delay the HCC Exception Score Assignment (Resolution 9) Liver and Intestine Committee David Mulligan, Chair November 12 and 13, 2014.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
Authorizing Collective Patient and Wait Time Transfers Operations and Safety Committee Fall 2014.
Liver and Intestinal Organ Transplantation Committee Update Report David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Proposed Membership and Personnel Requirements for OPTN Designation & Approval of Intestine Transplant Programs Liver and Intestinal Organ Transplantation.
Liver and Intestinal Organ Transplantation Committee Report to the Board of Directors June 25-26, 2012 Richmond, VA Kim M. Olthoff, MD, Chair David C.
1 Proposal to Revise Facilitated Pancreas Allocation Policy Pancreas Transplantation Committee Fall 2015.
Ad Hoc Disease Transmission Advisory Committee Fall 2014.
Operations and Safety Committee Update Report to Board of Directors June , 2012 Phil Camp, Jr., MD - Chair.
Redesigning Liver Distribution David Mulligan, MD, Chair Liver & Intestinal Organ Transplantation Committee November 12-13, 2014.
Clarify Policy Language and Process for Individual Waiting Time Transfer Patient Affairs Committee Spring 2015.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
Enhancing Liver Distribution
National Liver Review Board (NLRB)
Pediatric Transplantation Committee
Membership & Professional Standards Committee (MPSC)
Liver Transplantation: 50 years
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Thoracic Organ Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
Liver and Intestinal Organ Transplantation Committee Update Report
Changes to HCC Criteria for Auto Approval
OPTN/UNOS Thoracic Organ Transplantation Committee
Pancreas Program Functional Inactivity
Liver & Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Action Items from the Kidney Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
OPTN/UNOS Transplant Coordinators Committee
Pancreas Transplantation Committee Update
Operations and Safety Committee
Liver and Intestine Committee
Membership & Professional Standards Committee (MPSC)
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Proposal to Delay the HCC Exception Score Assignment
Proposal to Notify Patients Having an Extended Inactive Status
Liver and Intestinal Organ Transplantation Committee Spring 2014
Liver & Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Thoracic Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee Spring 2014
Pancreas Transplantation Committee
Liver & Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee Spring 2014
MELD Exception Scores During NLRB Transition
Proposal to Delay the HCC Exception Score Assignment
Pediatric Transplantation Committee Fall 2014
Pancreas Transplantation Committee Update
Histocompatibility Committee
Pancreas Transplantation Committee Update
Membership & Professional Standards Committee (MPSC)
MPSC Transplant Program Performance Measures (Outcome Measures)
VCA Committee Update Spring 2015.
Proposal to Cap the HCC Exception Score at 34
Pediatric Transplantation Committee
Pancreas Transplantation Committee
Presentation transcript:

OPTN Liver and Intestinal Organ Transplantation Committee Update Spring 2012 Kim Olthoff, MD, Chair David Mulligan, MD, Vice-chair

OPTN Proposals Circulated Fall 2011  Public Comment ended 12/23/2011  Committee met 03/15/2012, reviewed comments Share 15 National will be submitted to the Board of Directors in June Share 35 Regional - Several decisions: Will apply to MELD/PELD exceptions No Sharing Threshold Awaiting data on Liver-Kidney before decision Will meet by call in April or May to vote on Board submission

OPTN Other Committee Initiatives  MELD Enhancements & Exceptions Subcommittee MELD Refit (with or without Na) Review of issues with MELD/PELD exceptions / Review Boards Revisit PELD Score  Liver Utilization Subcommittee Reducing discards “Facilitated Placement”

OPTN Other Committee Initiatives  HCC Subcommittee Explant Pathology Form – Going online Will replace faxed forms System notice 2 weeks prior HCC Hold Proposal (Spring 2012) HCC Allocation Issues  Status 1 Review Subcommittee Ongoing real-time review of Status 1A/B cases not meeting criteria

OPTN Questions?

OPTN Liver and Intestinal Organ Transplantation Committee Proposal for Public Comment Spring 2012

OPTN Proposal to Allow Centers to Place Liver Candidates with HCC Exceptions on ‘HCC Hold’ Without Loss of Accumulated MELD Exception Score (“HCC Hold”)

OPTN PROBLEM STATEMENT / BACKGROUND

OPTN Problem Statement - I Currently:  Candidates listed with an HCC exception continue to receive increases in priority every three months regardless of whether the tumors have shown progression  As score increases (22, 25, 28, etc.) candidates begin to receive offers  Centers may wish to inactivate some candidates until there is demonstrated tumor progression: Candidates initially listed with small tumors Those with well-treated tumors

OPTN Problem Statement - II  No mechanism to do this without: Automatic increases in score (if extended while inactivated) OR Loss of accumulated score (if not extended while inactive  If inactivated, centers must submit extensions every three months Otherwise candidate loses accumulated MELD score Score continues to increase even though risk of drop-out may be low

OPTN Proposal  Allow centers to place liver candidates with HCC Exceptions on ‘HCC Hold’ without loss of accumulated MELD exception score and without mandatory/standard increases in the score q 3 mo  In practice: Candidate is inactivated, reason provided is “HCC hold”

OPTN Benefits  Will eliminate offers for high-MELD patients that the center is not yet ready to transplant Improve efficiency of the system (fewer turndowns) Decrease required applications for extensions, and tests required to complete applications  Allows centers to utilize different ways of treating these patients (e.g., TACE, RFA), while providing the safety net of transplant if/when tumor recurs or demonstrates growth

OPTN Summary Current Process in UNet ℠ Proposed Change Centers can extend an approved HCC Exception while candidate is in inactive status. No change. Approved HCC Exception applications must be extended every 3 months, even while the candidate is in inactive status. If the application is not extended, the candidate will lose the accumulated exception score upon re-activation. Approved HCC Exception applications may remain on ‘HCC hold’ as long as a candidate is in inactive status; once re-activated, the candidate will retain the accumulated exception score (most recent tumor information must be provided).

OPTN Current Process in UNet ℠ Proposed Change Upon extension of an approved HCC Exception, the MELD score increases by the equivalent of a 10 percentage point increase in the risk of 3- month mortality. Upon re-activation and extension of an approved HCC Exception, the MELD score could remain fixed. Summary II

OPTN Example A (p. 62 of proposal)  1/1/2012: Candidate has approved HCC exception, one 2.1 cm tumor (MELD 22).  Exception extended 4/1 (25) and 7/1 (28).  Candidate begins receiving offers; tumor size still 2.1cm  Transplant team decides to observe tumor behavior before proceeding to transplant  Candidate placed on “HCC hold,” periodically undergoes CT to monitor the lesion.

OPTN Example A (p. 62 of proposal)  12/10/12: CT shows tumor has grown to 2.8 cm.  12/15/12: Center submits the routine tumor information and activates candidate  Candidate’s score of 28 maintained until the next extension

OPTN Example B (p. 62 of proposal)  1/1/2012: Candidate has approved HCC exception, one tumor treated with RFA that is 2.5 cm in size (MELD 22).  Exception extended 4/1 (25) and 7/1 (28).  Candidate begins receiving offers, however the candidate has an ablation defect with no evidence of viable tumor  Transplant team decides to observe tumor behavior before proceeding to transplant.  Candidate placed on “HCC hold,” periodically undergoes CT to monitor the lesion.

OPTN Example B (p. 62 of proposal)  1/1/13: CT shows no evidence of viable tumor at the ablation site but a new 1cm hypervascular lesion with wash out on delayed phase imaging.  1/5/13: Center submits the routine tumor information and activates candidate.  Candidate’s score of 28 is maintained until the next extension

OPTN Supporting Data  Candidates with small HCC tumors have a low probability of waiting list dropout or growth beyond current transplant criteria within 12 months of listing Washburn et al, AJT 2010 Massie, et al, AJT 2011

OPTN Policy The following options are available while a candidate with an approved HCC Exception application is in inactive status: T he center may choose to submit an extension application every 3 months, as described above; the candidate will receive a MELD/PELD score equivalent to a 10 percentage point increase in candidate mortality following each approved extension.

OPTN Policy The center may keep the candidate in inactive status for any length of time, without submission of an extension application every 3 months. However, prior to reactivation, an extension application must be submitted. Once the extension application is approved, the candidate will be listed with the candidate’s previously approved exception score prior to inactivation (i.e., without loss of the accumulated MELD/PELD exception score) upon re-activation.

OPTN Plan for Evaluating The Committee will review annually:  How often this option is used  Mean MELD/PELD scores at transplant, number and % of candidates removed from the waiting list for reasons other than transplant for candidates with HCC exceptions versus those without, by Region  Outcomes for candidates whose exception is placed on hold

OPTN Additional Information Additional Data Collection: These proposals do not require additional data collection (forms) in Tiedi SM Expected Implementation Plan: UNOS Information Technology (IT) staff will need to reprogram UNet SM to implement these algorithms

OPTN Questions?